Price
Target price
€5.75
€5.75
-3.850%
-0.23
-3.850%
€19.86
24.04.24 / Stuttgart Stock Exchange
WKN: A3DWPS / Symbol: KALA / Name: Kala Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Kala Pharmaceuticals Inc. Stock
Kala Pharmaceuticals Inc. took a tumble today and lost -€0.230 (-3.850%).
Our community is currently high on Kala Pharmaceuticals Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 19 € there is potential for a 230.43% increase which would mean more than doubling the current price of 5.75 € for Kala Pharmaceuticals Inc..
So far the community has only identified positive things for Kala Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | -3.850% | -4.167% | -17.060% | -56.062% | -8.282% | -98.096% | - |
| Ardelyx Inc. | -2.390% | -2.116% | -15.296% | 40.514% | 4.048% | -12.204% | - |
| Salarius Pharmaceuticals Inc. | -3.170% | 2.315% | -15.000% | -67.971% | -20.360% | -98.187% | -99.994% |
| Brainstorm Cell | 1.170% | -1.874% | -1.485% | -81.975% | 114.440% | -80.717% | - |
Comments
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $22.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $24.00 to $22.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat